Ventyx Biosciences Inc (NASDAQ: VTYX) started the day on Wednesday, with a price decrease of -3.81% at $2.02, before settling in for the price of $2.10 at the close. Taking a more long-term approach, VTYX posted a 52-week range of $1.79-$11.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -148.81%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.44%. This publicly-traded company’s shares outstanding now amounts to $59.24 million, simultaneously with a float of $54.72 million. The organization now has a market capitalization sitting at $142.83 million. At the time of writing, stock’s 50-day Moving Average stood at $2.24, while the 200-day Moving Average is $3.57.
Ventyx Biosciences Inc (VTYX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Ventyx Biosciences Inc’s current insider ownership accounts for 22.62%, in contrast to 72.79% institutional ownership. According to the most recent insider trade that took place on Apr 02 ’24, this organization’s CHIEF BUSINESS OFFICER sold 1,651 shares at the rate of 5.40, making the entire transaction reach 8,921 in total value, affecting insider ownership by 284,999. Preceding that transaction, on Apr 02 ’24, Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for 5.40, making the whole transaction’s value amount to 8,921. This particular insider is now the holder of 264,998 in total.
Ventyx Biosciences Inc (VTYX) Earnings and Revenue Records
Ventyx Biosciences Inc’s EPS increase for this current 12-month fiscal period is 36.44% and is forecasted to reach -2.15 in the upcoming year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Let’s observe the current performance indicators for Ventyx Biosciences Inc (VTYX). It’s Quick Ratio in the last reported quarter now stands at 23.52. The Stock has managed to achieve an average true range (ATR) of 0.14.
In the same vein, VTYX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.37, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -2.15 at the market close of one year from today.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
If we take a close look at the recent performances of Ventyx Biosciences Inc (NASDAQ: VTYX), its last 5-days Average volume was 0.94 million that shows plunge from its year to date volume of 2.04 million. During the previous 9 days, stock’s Stochastic %D was recorded 16.96% While, its Average True Range was 0.14.
Raw Stochastic average of Ventyx Biosciences Inc (VTYX) in the period of the previous 100 days is set at 16.20%, which indicates a major rise in contrast to 0.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.64% that was lower than 79.97% volatility it exhibited in the past 100-days period.
